The molecular targets associated with earlier stages of PCa, e.g., gastrin-releasing peptide receptors (GRPRs), could be utilized for the visualization of primary tumors, local recurrences, and extrapelvic LN metastatic lesions, potentially adding to diagnostic and staging accuracy. This evidence concerns the gene GRPR and posterior cortical atrophy.